Motrin Junior Strength and Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate
Determining the interaction of Motrin Junior Strength and Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibuprofen
Brand name: Children's Motrin, Motrin Junior Strength, Advil, Advil Liqui-Gels, Midol, Motrin, Motrin IB, Motrin Migraine Pain, Proprinal, Smart Sense Children's Ibuprofen, PediaCare Children’s Pain Reliever/Fever Reducer, PediaCare Infant’s Pain Reliever/Fever Reducer, Caldolor, NeoProfen, Genpril, Ibu, Midol IB
Synonyms: n.a.
Generic Name: carbetapentane / phenylephrine / potassium guaiacolsulfonate
Brand name:
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Motrin Junior Strength-Phenylephrine, Chlorpheniramine, and Carbetapentane Liquid
- Motrin Junior Strength-Phenylephrine, Chlorpheniramine, and Chlophedianol Suspension
- Motrin Junior Strength-Phenylephrine, Chlorpheniramine, and Codeine Syrup
- Motrin Junior Strength-Phenylephrine, Dexchlorpheniramine, and Codeine
- Motrin Junior Strength-Phenylephrine, Pyrilamine, and Chlophedianol Liquid
- Motrin Junior Strength-Phenylephrine, Thonzylamine, and Dextromethorphan Liquid
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Motrin PM
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Motrin Tablets
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Movantik
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-MoviPrep
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Moxatag
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Moxetumomab pasudotox